Clinical factors to predict engraftment in low CD34 count autologous hematopoietic stem cell transplantation in patients with lymphoma and myeloma

被引:0
|
作者
Kim, Sang-A [1 ]
Shin, Dong-Yeop [1 ]
Koh, Youngil [1 ]
Hong, Junsik [1 ]
Kim, Inho [1 ]
Yoon, Sung-Soo [1 ]
机构
[1] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P224
引用
收藏
页码:310 / 311
页数:2
相关论文
共 50 条
  • [1] Engraftment Outcome with Autologous Hematopoietic Stem Cell Collection When Peripheral CD34 Count Is Too Low to Report
    Lu, Wen
    Dumont, Carol
    Serafino, Sheila
    Katanik, Debbi
    Figueroa, Priscilla I.
    [J]. TRANSFUSION, 2018, 58 : 72A - 72A
  • [2] IMPACT OF CD34 CELL DOSE ON PLATELET ENGRAFTMENT AND PLATELET TRANSFUSIONS FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Shariatmadar, S.
    Pereira, D.
    Smith, R.
    Goodman, M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S205 - S205
  • [3] The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment
    Sari, Tamer
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Tol, Meltem
    Ayyildiz, Erol
    Ozcan, Muhit
    Ilhan, Osman
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2010, 43 (03) : 315 - 320
  • [4] CD34+Hematopoietic Progenitor Cell Dose as a Predictor of Engraftment and Survival in Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation
    Aladag, Elifcan
    Demiroglu, Haluk
    Buyukasik, Yahya
    Goker, Hakan
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 407 - 407
  • [5] CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
    Aladag, Elifcan
    Demiroglu, Haluk
    Buyukasik, Yahya
    Turgut, Mehmet
    Aksu, Salih
    Sayinalp, Nilgun
    Haznedaroglu, Ibrahim Celalettin
    Ozcebe, Osman Ilhami
    Goker, Hakan
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (08) : 1851 - 1856
  • [6] Relationship between CD34 positive stem cell dose and time to engraftment in autologous stem cell transplantation.
    Ault, KA
    Case, DC
    Boyd, MA
    Ervin, TJ
    Aronson, FR
    Ebrahim, KS
    Hedlund, JA
    [J]. BLOOD, 1999, 94 (10) : 397B - 397B
  • [7] DO CD34(+) CELL COUNTS PREDICT HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT)
    MIJOVIC, A
    MUFTI, GJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) : 226 - 227
  • [8] Double autologous stem cell transplantation with CD34 selected cells for multiple myeloma.
    Nedellec, G
    Ceccaldi, B
    Fagot, T
    Souleau, B
    Traulle, C
    Merrer, J
    De Revel, T
    Joussemet, M
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S137 - S137
  • [9] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH PLASMA CELL MYELOMA OR LYMPHOMA
    Ozkan, H. A.
    Ozer, U. G.
    Cekdemir, D.
    Gulbas, Z.
    [J]. HAEMATOLOGICA, 2014, 99 : 726 - 726
  • [10] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH PLASMA CELL MYELOMA OR LYMPHOMA
    Ozkan, H. A.
    Ozer, U. Guney
    Gulbas, Z.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452